ViaDor-Calcitonin

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameViaDor-Calcitonin
Drug Alias NameViaDerm-Calcitoninpeptide (TransPharma)Calcitonin (TransPharma Medical)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCalcitonin receptor agonists
TargetsCalcitonin receptor
Therapy Area/IndicationsMusculoskeletal PainOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTranspharma Medical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranspharma Medical
Active IndicationsN/A
Inactive IndicationsMusculoskeletal PainOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A